Portfolio returned 31.9% vs 29.1% benchmark, but NPAT fell 2.2%

Net assets attributable rose to $7.6b and total assets to $9.1b, reflecting the market rebound rather than fresh capital deployment.

Income from the portfolio moved in the opposite direction. NPAT fell 2.2% to $235.1m and PBT slipped 4.0% to $248.0m, even as revenue from operating activities edged up 1.9% to $262.8m. The result reflects COVID-era dividend cuts and resets from underlying holdings that depressed cash income received.

The final dividend was held at 14.0 cents fully franked, taking the full-year distribution to 23.0 cents per share. Gross borrowings remained nil and the management expense ratio held at 0.14%, the lower edge of the company's historical range.

The portfolio beat its benchmark by 2.8pp on a 29.1% benchmark return that is itself above the historical baseline (mean 11.7%, range 5.1%–16.6%). Almost all of the $1.5b total return is unrealised fair-value movement rather than cash income, so the headline number reads very differently from the cash that funds distributions.

Distribution coverage is tight. Distributions paid of $221.8m absorbed roughly 106% of investment income; coverage is only marginally positive, with no buffer of retained earnings assumed in that bridge. Holding the final dividend flat at 14.0 cents — rather than partially restoring — signals confidence in income recovery rather than current-period generation.

ROE has weakened versus the historical baseline. Current ROE of 3.1% sits below the historical range of 3.6%–5.2% (mean 4.3%), reflecting a swollen equity base from market gains against suppressed dividend income. The effect is mechanical, but it constrains the income return shareholders can expect on rebased NAV until investee dividends recover.

Management commentary emphasises long-run growth in fully franked dividends and a preference for "earnings... strong cash flow and balance sheet" assets — language consistent with maintaining the distribution as underlying company payouts normalise. The release does not commit to a specific FY22 income trajectory.

The shape of the year is informative. HY21 delivered $96.2m of revenue (36.6% of full-year) and $83.7m NPAT (35.6%), implying a stronger second half as Australian corporate dividends partially recovered. Whether that recovery extends through FY22 is the central unstated question this filing leaves open.

The $1.5b investment total return is dominated by unrealised capital movements, which can reverse with the market; the cash income line of $235.1m is the durable, distributable element and that has fallen short of the three-year historical mean of $338.9m by about $103.8m.

Operating cash inflows of $178.8m were below the prior $254.6m, mirroring the dividend-income shortfall from the portfolio rather than any working-capital effect, which does not meaningfully apply to a listed investment company. Distribution coverage of 106% therefore looks adequate on the year but is thin relative to the historical pattern where income comfortably exceeded distributions. The 0.14% expense ratio and zero gross borrowings preserve flexibility, leaving the result's durability tied almost entirely to underlying investee dividend recovery rather than anything within management's direct control.

This briefing cannot assess the realised versus unrealised split inside the $1.5b total return, individual investee dividend forecasts, or the franking credit balance available to support future fully franked distributions.